Stabilized micelles have shown prolonged blood circulation and targeting to solid tumors through enhanced permeability and retention (EPR) effect. It has been demonstrated that Intezyne's Versatile Encapsulation and Crosslinking Technology (IVECT™) has the advantage of allowing the micelles to be crosslinked via a pH-sensitive Fe(III) metal coordination reaction that permeates xenografted tumors and clears from circulation without retention in the kidneys or liver. In this work we developed a theragnostic method to study drug delivery over time of IVECT by T1-weighted image histogram and image intensity in the tumor, kidneys, liver and muscle in a HCT116 Xenograft Model.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords